PRNewsWire
09 Jun 2026, 01:23 UTC · 2h ago
Eloxx Pharmaceuticals, Inc. Announces Pricing of $66.0 Million Public Offering and Uplisting to Nasdaq
Search tags
PRNewsWire
09 Jun 2026, 01:23 UTC · 2h ago
Search tags
Story key points
2 claims · impact-rated
Eloxx Pharmaceuticals is conducting a public offering of common stock and pre-funded warrants to raise $66 million in gross proceeds. — Public offerings typically cause short-term share price dilution for existing stockholders.
-0.30Eloxx Pharmaceuticals is uplisting its shares to the Nasdaq Capital Market under the symbol 'ELOX' starting June 9, 2026. — Uplisting to a major exchange generally increases liquidity, visibility, and institutional investor access.
+0.20Ticker attribution
Model heads
The company is raising $66 million in capital and successfully uplisting to the Nasdaq.
Continue reading
6 related stories
No ticker relationship head found.
Early access
News Impact Screener scores every headline against the stocks it moves — before the chart reacts. Join the early-access list and get alerted the moment a story hits your tickers.
Impact vectors
2 dimensions · 9 clusters
Market reaction
10 bid · 10 offered
GlobeNewsWire
1h ago
